Concerto Biosciences, Inc.
Biotechnology company · Allston, Massachusetts, United States
Concerto Biosciences, Inc. is a biotechnology company headquartered in Allston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,907 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2022.
Concerto Biosciences at a glance
What does Concerto Biosciences do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $299,907 in total (2022). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $24.5 million sold (2022).
Frequently asked questions about Concerto Biosciences
Where is Concerto Biosciences headquartered?
Concerto Biosciences, Inc. is headquartered in Allston, Massachusetts, United States.
What does Concerto Biosciences do?
Concerto Biosciences, Inc. is a biotechnology company.
When was Concerto Biosciences founded?
The earliest incorporation on record for Concerto Biosciences, Inc. is in 2020, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.